Market Research Logo

Egypt Pharmaceuticals & Healthcare Q4 2018

Egypt Pharmaceuticals & Healthcare Q4 2018

Key View:

Egypt will remain an attractive yet challenging market for multinational pharmaceutical firms. The near-term pictureremains uncertain as the weak currency and regulations over drug pricing continue to create difficult market conditions. Thecountry's designation as a ‘Watch List' country in PhRMA's 2018 submission highlights discriminatory market access policies, andlow levels of intellectual property protection as ongoing concerns for multinational drugmakers. Egypt's long-term story is morepositive, and the country will benefit from a number of key pharmaceutical market drivers, supporting a greater multinationalpresence.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
MENA Innovative Pharmaceuticals Risk/Reward Index
Egypt Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Amoun Pharmaceutical Company (APC)
Egyptian International Pharmaceutical Industries Co (EIPICO)
Medical Union Pharmaceuticals
South Egyptian Drug Industries (SEDICO)
VACSERA
Egypt Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report